5-alpha reductase inhibitors (5-ARIs)

February 15, 2017February 15, 2017

No Elevated Breast Cancer Risk Seen in BPH Patients Treated with 5ARIs in Study

News

Treating benign prostatic hyperplasia (BPH) with 5-alpha reductase inhibitors can increase breast size in men, a condition called gynecomastia, but they don’t raise a person’s risk of breast cancer, according to a ... Read more

February 3, 2017February 3, 2017

BPH Patients Using 5-ARIs Not at Higher Risk of Dying of Prostate Cancer, Study Reports

News

Patients with benign prostatic hyperplasia (BPH) who are treated with enzyme 5-alpha reductase inhibitors (5-ARIs) are not at a higher risk of dying of prostate cancer than those using α-blockers, a new study reports. ... Read more